Literature DB >> 10688751

Use of alveolar cell monolayers of varying electrical resistance to measure pulmonary peptide transport.

A N Dodoo1, S S Bansal, D J Barlow, F Bennet, R C Hider, A B Lansley, M J Lawrence, C Marriott.   

Abstract

The apparent permeability coefficient (P(app)) of two fluorescently tagged model hydrophilic peptides, acXASNH(2) and acXAS(GAS)(7)NH(2), and (14)C-mannitol across monolayers of cultured rat alveolar epithelial cells of varying transepithelial electrical resistance (TER) has been examined. In line with their design features, the peptides were not degraded under the conditions of the test. Furthermore, no concentration dependence of transport of the tripeptide acXASNH(2) was observed over the concentration range studied, nor was any directional transport seen for either of the model peptides, indicating that under the conditions of the test they were not substrates for any transporters or efflux pumps. From the hydrophilic nature of the peptides (as assessed by their log P), and their inverse dependence of transport with molecular weight and TER, it was assumed that the peptides were transported across the cell monolayer passively via the paracellular route. The observed P(app) for the transport of (14)C-mannitol and the peptides across rat alveolar epithelial cell monolayers were found to be inversely (though not linearly) related to the measured TER and could be well-modeled assuming the presence of two populations of "pores" in the cell monolayer, namely, cylindrical pores of diameter 1.5 nm and large pores of diameter 20 nm. The relative populations of the two types of pores varied with the TER of the monolayer, with the number of large pores decreasing with an increase in TER (and the number of small pores taken as fixed). These results suggest that if the cell monolayer is well characterized with respect to the passage of a range of probe molecules across monolayers of varying electrical resistance, it should be possible to predict the P(app) of any hydrophilic peptide or drug crossing the membrane by the paracellular route at any desired TER using a monolayer of any electrical resistance, above a minimum value. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10688751     DOI: 10.1002/(SICI)1520-6017(200002)89:2<223::AID-JPS9>3.0.CO;2-R

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

1.  Conjugation with cationic cell-penetrating peptide increases pulmonary absorption of insulin.

Authors:  Leena N Patel; Jeffrey Wang; Kwang-Jin Kim; Zea Borok; Edward D Crandall; Wei-Chiang Shen
Journal:  Mol Pharm       Date:  2009 Mar-Apr       Impact factor: 4.939

2.  Serially passaged human nasal epithelial cell monolayer for in vitro drug transport studies.

Authors:  Jin-Wook Yoo; You-Sun Kim; Sun-Hee Lee; Min-Ki Lee; Hwan-Jung Roh; Byung-Hak Jhun; Chi-Ho Lee; Dae-Duk Kim
Journal:  Pharm Res       Date:  2003-10       Impact factor: 4.200

3.  Inflammatory response and barrier properties of a new alveolar type 1-like cell line (TT1).

Authors:  Ellen H J van den Bogaard; Lea Ann Dailey; Andrew J Thorley; Teresa D Tetley; Ben Forbes
Journal:  Pharm Res       Date:  2009-02-06       Impact factor: 4.200

4.  Characteristics of Passive Solute Transport across Primary Rat Alveolar Epithelial Cell Monolayers.

Authors:  Yong Ho Kim; Kwang-Jin Kim; David Z D'Argenio; Edward D Crandall
Journal:  Membranes (Basel)       Date:  2021-04-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.